The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis-Reference-Cited by-同舟云学术

The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis

Published:2015-12-17 Issue:8 Volume:31 Page:892-904
ISSN:0885-6230
Container-title:International Journal of Geriatric Psychiatry
language:en
Short-container-title:Int J Geriatr Psychiatry

Author:

Kobayashi Hisanori¹,Ohnishi Takashi¹,Nakagawa Ryoko¹,Yoshizawa Kazutake¹

Affiliation:

1. Evidence Generation Department, Medical Affairs Division; Janssen Pharmaceutical K.K.; Tokyo Japan

Funder

Janssen Pharmaceutical K.K. of Johnson & Johnson

Publisher

Wiley

Subject

Psychiatry and Mental health,Geriatrics and Gerontology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/gps.4405/fullpdf

Reference46 articles.

1. Cholinesterase inhibitors for Alzheimer's disease;Birks;Cochrane Database Syst Rev,2006

2. Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease;Brodaty;Dement Geriatr Cogn Disord,2005

3. General methods for monitoring convergence of iterative simulations;Brooks;J Comput Graph Stat,1997

4. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period;Bullock;Curr Med Res Opin,2005

5. The effects of donepezil in Alzheimer's disease-results from a multinational trial;Burns;Dement Geriatr Cogn Disord,1999

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence;Nutrients;2024-08-15

2. Efficacy of 5 and 10 mg donepezil in improving cognitive function in patients with dementia: a systematic review and meta-analysis;Frontiers in Neuroscience;2024-07-22

3. Combination Drug Therapy for the Management of Alzheimer’s Disease;Russian Journal of Geriatric Medicine;2024-06-30

4. Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer’s disease: A systematic review and meta-analysis;Advances in Clinical and Experimental Medicine;2024-03-01

5. Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management;Journal of Controlled Release;2024-03